Using advanced imaging to improve radiation therapy for glioblastoma in small animals
Quantitative bioluminescence tomography for pre-clinical radiotherapy
This study is looking at new ways to make radiation therapy for glioblastoma better by using advanced imaging techniques to help doctors target tumors more accurately, which could lead to improved treatment results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10630901 on NIH RePORTER |
What this research studies
This research focuses on enhancing radiation therapy for glioblastoma by integrating advanced imaging techniques. It utilizes a small-animal radiation research platform that combines cone-beam CT with 3D bioluminescence tomography to improve the targeting of tumors. By providing better localization of soft tissue tumors, this approach aims to refine pre-clinical studies and improve treatment outcomes. The research seeks to address the limitations of current imaging methods to ensure more precise irradiation of tumors in animal models.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glioblastoma or those involved in pre-clinical studies related to this condition.
Not a fit: Patients with conditions other than glioblastoma or those not involved in pre-clinical research may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective radiation therapy techniques for glioblastoma, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for tumor targeting, indicating potential success for this novel approach.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Wang, Ken Kang-Hsin — Ut Southwestern Medical Center
- Study coordinator: Wang, Ken Kang-Hsin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.